TNFα reduces tachykinin, PGE2‐dependent, relaxation of the cultured mouse trachea by increasing the activity of COX‐2
Authors:
- 29 January 2005
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 144 (2) , 220-230
Abstract
Chronic inflammation is a central feature of asthma. The inflammatory cytokine tumour necrosis factor α (TNFα) has been implicated in this disease, and is known to alter airway smooth muscle functionally. The aim of this study was to investigate the influence of TNFα on tachykinin‐induced airway relaxation. Mouse tracheae were cultured in the absence and presence of TNFα for 1 or 4 days. In the absence of TNFα, substance P (SP) and neurokinin A (NKA) induced comparable levels of relaxation in fresh and cultured segments. Functional studies with selective antagonists/inhibitors indicated that the relaxation was mediated by the NK1 receptor coupled to cyclooxygenase (COX)‐2 activation and subsequent release of prostaglandin E2 (PGE2). TNFα attenuated SP‐ and NKA‐induced relaxation in a time‐ and concentration‐dependent manner, decreasing the ability of PGE2 to relax tissues. Further studies indicated that TNFα elevated COX‐2 activity and that concomitant inhibition of COX‐2 reversed TNFα‐attenuated PGE2 relaxation. Culture with PGE2 decreased SP‐ and PGE2‐mediated relaxation, further implicating the activity of COX‐2 in the attenuation of tachykinin signalling. Gene expression analysis demonstrated that TNFα increased the expression of smooth muscle COX‐2, PGE2 synthase and EP2 receptor mRNA, and decreased the expression of the EP4 receptor. Overall, these results show that NK1 receptor‐mediated relaxation induced by PGE2 is attenuated by prolonged TNFα stimulation. Increased COX‐2 activity induced by TNFα appears to be central to this process. British Journal of Pharmacology (2005) 144, 220–230. doi:10.1038/sj.bjp.0706067Keywords
This publication has 36 references indexed in Scilit:
- An assay to evaluate the long‐term effects of inflammatory mediators on murine airway smooth muscle: evidence that TNFα up‐regulates 5‐HT2A‐mediated contractionBritish Journal of Pharmacology, 2002
- Optimisation of real-time quantitative RT-PCR for the evaluation of non-viral mediated gene transfer to the airwaysGene Therapy, 2002
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001
- Characteristics of the Inflammatory Response in Bronchial Lavage Fluids from Patients with Status asthmaticusInternational Archives of Allergy and Immunology, 2001
- Role of PGE2 in protease‐activated receptor‐1, −2 and −4 mediated relaxation in the mouse isolated tracheaBritish Journal of Pharmacology, 2001
- Induction of cyclo‐oxygenase‐2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell typeBritish Journal of Pharmacology, 1997
- A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymesTrends in Pharmacological Sciences, 1997
- Cytokines in symptomatic asthma airwaysJournal of Allergy and Clinical Immunology, 1992
- A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptorLife Sciences, 1992
- Effect of inhaled prostaglandin E2 on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma.Thorax, 1991